Cargando…

S225. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PHARMACOLOGICAL INTERVENTIONS FOR REDUCTION OR PREVENTION OF WEIGHT GAIN IN SCHIZOPHRENIA

BACKGROUND: Weight gain is an extremely common problem in schizophrenia patients and is associated with morbidity and mortality. We conducted a Cochrane meta-analysis to determine the effects of pharmacological interventions aimed at reduction or prevention of weight gain in schizophrenia. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Sri Mahavir, Ahsan, Zohra, Lockwood, Jonathan, Duncan, Marcus, Takeuchi, Hiroyoshi, Cohn, Tony, Taylor, Valerie, Remington, Gary, Faulkner, Guy, Hahn, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888131/ http://dx.doi.org/10.1093/schbul/sby018.1012

Ejemplares similares

S90. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PHARMACOLOGICAL INTERVENTIONS FOR REDUCTION OF WEIGHT GAIN IN PEOPLE WITH SCHIZOPHRENIA: 2019 UPDATE
por: Agarwal, Sri Mahavir, et al.
Publicado: (2020)

F225. LEVODOPA AUGMENTATION OF ANTIPSYCHOTICS FOR THE TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Foussias, George, et al.
Publicado: (2018)

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis
por: Kanagasundaram, Pruntha, et al.
Publicado: (2021)

Metabolic Syndrome in Schizophrenia: Theoretical, Clinical and Translational Perspectives
por: Agarwal, Sri Mahavir, et al.
Publicado: (2013)

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
por: Stogios, Nicolette, et al.
Publicado: (2021)

Treating Negative Symptoms in Schizophrenia: an Update
por: Remington, Gary, et al.
Publicado: (2016)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
por: Prasad, Femin, et al.
Publicado: (2023)

Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia
por: Costa-Dookhan, Kenya A., et al.
Publicado: (2021)

Cognitive Mapping Deficits in Schizophrenia: A Critical Overview
por: Bose, Anushree, et al.
Publicado: (2014)

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
por: Singh, Raghunath, et al.
Publicado: (2022)

The Utility of the Health Action Process Approach Model for Predicting Physical Activity Intentions and Behavior in Schizophrenia
por: Arbour-Nicitopoulos, Kelly P., et al.
Publicado: (2017)

Development and Reliability Testing of a Health Action Process Approach Inventory for Physical Activity Participation among Individuals with Schizophrenia
por: Arbour-Nicitopoulos, Kelly P., et al.
Publicado: (2014)

Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder
por: Subramaniapillai, Mehala, et al.
Publicado: (2016)

T231. QUALITY OF LIFE IN ANTIPSYCHOTIC-NAïVE YOUTH: EXPLORING THE INTERPLAY WITH METABOLIC SIDE-EFFECTS
por: Chintoh, Araba, et al.
Publicado: (2020)

M84. METFORMIN FOR EARLY CO-MORBID PREDIABETES OR DIABETES IN SCHIZOPHRENIA SPECTRUM DISORDERS: A DOUBLE BLIND RANDOMIZED PILOT STUDY
por: Mahavir Agarwal, Sri, et al.
Publicado: (2020)

S89. INVESTIGATING METABOLIC DYSFUNCTION AND METABOLOMIC PROFILE CHANGES IN ANTIPSYCHOTIC NAIVE PATIENTS
por: Costa-Dookhan, Kenya, et al.
Publicado: (2020)

S76. A BEHAVIOURAL ECONOMIC ANALYSIS OF EFFORT-RELATED CHOICE IN SCHIZOPHRENIA
por: Fervaha, Gagan, et al.
Publicado: (2018)

Non-invasive neuromodulation of dorsolateral prefrontal cortex to reduce craving in alcohol use disorder: A meta-analysis
por: Sorkhou, Maryam, et al.
Publicado: (2022)

Transcranial Direct Current Stimulation in Schizophrenia
por: Agarwal, Sri Mahavir, et al.
Publicado: (2013)

ACCIDENTA C-225
por: Departments, HR
Publicado: (2010)

Clinical correlates of parametric digit-symbol substitution test in schizophrenia
por: Amaresha, Anekal C., et al.
Publicado: (2014)

F121. DOES RELAPSE CONTRIBUTE TO TREATMENT RESISTANCE? ANTIPSYCHOTIC RESPONSE IN FIRST- VS. SECOND-EPISODE SCHIZOPHRENIA
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2018)

Synthesis and Stability of Actinium-225 Endohedral Fullerenes, (225)Ac@C(60)
por: Mwakisege, Jofa Gideon, et al.
Publicado: (2020)

Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: A pilot study
por: Lee, Jiwon, et al.
Publicado: (2023)

Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia
por: Oh, Nicholas, et al.
Publicado: (2016)

Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
por: Stogios, Nicolette, et al.
Publicado: (2022)

Editorial: Cardiovascular and Physical Health in Severe Mental Illness
por: Agarwal, Sri Mahavir, et al.
Publicado: (2021)

Termodinamica: 225 problemi risolti
por: Abbott, Michael M, et al.
Publicado: (1994)

The nuclear structure of $^{225}$Ra
por: Nybø, K, et al.
Publicado: (1983)

Spectroscopic studies of francium 225
por: García-Borge, M J, et al.
Publicado: (1987)

Measurements of multipolarities in $^{225}$Ra
por: Andersen, E, et al.
Publicado: (1988)

Physical health among people with serious mental illness in the face of COVID-19: Concerns and mitigation strategies
por: Melamed, Osnat C., et al.
Publicado: (2020)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

S55. MECHANISTIC BASIS OF FRONTO-TEMPORAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON AUDITORY VERBAL HALLUCINATION IN SCHIZOPHRENIA: A MEDIATION ANALYSIS OF COROLLARY DISCHARGE
por: Bose, Anushree, et al.
Publicado: (2018)

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial
por: Agarwal, Sri Mahavir, et al.
Publicado: (2021)

Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis
por: Wu, Sally, et al.
Publicado: (2023)

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2021)

Seagate ST-225 Hard Drive
Publicado: (1984)

Health Tract, No. 225: Dirty Children
Publicado: (1864)

Cannot write session to /tmp/vufind_sessions/sess_ah6689h9psesojr50r839hinln